PDF Download the Lipotek Case Study (PDF 168kB)

Lipotek, a Canberra-based biotechnology company, conducts research and develops targeted therapies designed to fight disease with the fewest side effects possible.

Finalists at last year’s ACT Chief Minister’s Export Awards, Chief Executive Officer at Lipotek, Dr Ines Atmosukarto, said the ‘designer vaccines’ concept the company developed were then sold on to pharmaceutical companies around the world where it will be applied to fight diseases such as cancer and tuberculosis.

Dr Atmosukarto said one of the most beneficial experiences she took from the awards was the application process.

“It was unexpected, but the application process was a great way to step back and look at the company from another person’s point of view,” Dr Atmosukarto said. “It’s useful to know what other people see when they approach your business, so it was helpful to get that new perspective.”
She said it the application process was made extremely easy too, with a representative from the ACT Export Awards contacting her once the business had expressed interest to offer assistance.

“Their help was great and very welcome. We haven’t applied for many awards, so to have that extra advice was really worthwhile.”

Dr Atmosukarto said being a finalist also proved to be positive for Lipotek, with the Award lending the company credibility.

“We are a business working in a very small industry here in Canberra and it can be difficult to distinguish ourselves from those interstate. An award such as the ACT Chief Minister’s Export Awards has given us more exposure, more credibility and has given the business a good deal of confidence in what we do, thanks to what we have achieved.”

“The experience has been extremely valuable and I recommend any business that exports to give the Awards a go.”

The ACT Chief Minister's Export Awards are an initiative of the ACT Government, managed and delivered by the Canberra Business Council.

Return to Business and Innovation stories